Qzome™ — The next-generation niosomal platform for advanced nutraceutical delivery.

Enhanced Stability. Targeted Release. High Active Loading. Qzome™ is an advanced niosomal delivery system engineered to stabilize sensitive bioactives and deliver them with superior efficiency. Built from ultra-stable non-ionic surfactants, Qzome™ creates highly resilient vesicles that protect the active, enhance absorption and enable precise targeted release throughout the gastrointestinal tract. Qzome™ combines the best of modern encapsulation engineering: high stability, strong membrane integrity, excellent active loading capacity, and cost-effective scalability — making it a perfect fit for next-generation nutraceutical formulations. ⸻ Core Performance Advantages • Advanced stability under heat, oxidation, humidity and pH variations • Targeted release in the intestinal environment • High active loading, ideal for both lipophilic and hydrophilic compounds • Superior protection for sensitive actives vs. conventional emulsions • Optimized membrane integrity, enabling consistent delivery (Aligné avec la brochure : Advanced stability – Targeted release – High active loading) ⸻ Why Qzome™ Elevates Probiotic & Postbiotic Formulations Qzome™ is ideally suited for probiotic, postbiotic and microbiome-support actives, thanks to its unique structural resilience: • Exceptional protection in harsh gastric conditions • Improved viability and functional delivery • Enhanced bioactivity due to targeted intestinal release • Compatible with native, multi-patented, ultra-stable strains • Synergistic with strains featuring ≥ 90% gastric survival • Supports biological effects on microbiome, immunity, digestion and metabolism